Instrument Inactif

Autres langues Hercules Technology Growth Capital Inc Nasdaq

Actions

US4270965084

Temps réel estimé Cboe BZX Autres places de cotation 20:18:12 28/05/2024			Varia. 5j.	Varia. 1 janv.
19,4 ^USD	0,00%		0,00%	0,00%

17/05	HERCULES CAPITAL, INC. : UBS n'est pas inspiré par le dossier	ZM
09/05	X4 Pharmaceuticals reçoit 125 millions de dollars de capitaux supplémentaires ; les actions augmentent	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Hercules Capital : 2025 Proxy Statement	17/05
Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital	15/05
Hercules Capital Announces Date of 2024 Annual Meeting of Stockholders	13/05
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS	10/05
Electric Hydrogen secures $100M credit facility from HSBC, J.P. Morgan, Stifel Bank and Hercules Capital to decarbonize critical industries at scale	10/05
X4 Pharmaceuticals Receives $125 Million Additional Capital; Shares Rise	09/05
Verona Pharma Signs Financing Agreements for Up to $650 Million	09/05
X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility	09/05
Hercules Capital Announces Upcoming Event for the Financial Community	07/05
Hercules Capital: Q1 Earnings Snapshot	02/05
Hercules Capital, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Hercules Capital Reports First Quarter 2024 Financial Results	02/05
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024	30/04
Hercules Capital, Inc. Declares First Quarter Cash Dividend, Payable on May 14, 2024	30/04
Hercules Capital Signs $35 Million Loan Facility to Fund Development of Tenosynovial Giant Cell Tumour Treatment	30/04
Hercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative Originations	24/04
Hercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference Call	18/04
KARL STORZ SE & Co. KG entered into an agreement to acquire Asensus Surgical, Inc. for $100 million.	03/04
Hercules Capital Receives BBB- Affirmed Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.	27/03
Bluebird bio to Restate Financial Statements; Shares Fall	26/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Hercules Technology Growth Capital Inc Nasdaq

Actions

US4270965084

Autres langues

Filtres